primescript rt master mix reverse transcription kit Search Results


rt pre mix kit  (iNtRON Biotechnology)
90
iNtRON Biotechnology rt pre mix kit
Rt Pre Mix Kit, supplied by iNtRON Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/us11020358-210-19-25?v=iNtRON+Biotechnology
Average 90 stars, based on 1 article reviews
rt pre mix kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
primescript rt reagent kit  (BGI Genomics Co)
90
BGI Genomics Co primescript rt reagent kit
Primescript Rt Reagent Kit, supplied by BGI Genomics Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/pmc11986740-80-16-20?v=BGI+Genomics+Co
Average 90 stars, based on 1 article reviews
primescript rt reagent kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
taqman gene expression master mix  (Thermo Fisher)
99
Thermo Fisher taqman gene expression master mix
Taqman Gene Expression Master Mix, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/pmc05880723-116-34-39?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
taqman gene expression master mix - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
easystep® rt master mix kit  (Promega)
90
Promega easystep® rt master mix kit
Easystep® Rt Master Mix Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/pm37006242-92-13-18?v=Promega
Average 90 stars, based on 1 article reviews
easystep® rt master mix kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
goscript rt mix oligodt kit  (Promega)
90
Promega goscript rt mix oligodt kit
Goscript Rt Mix Oligodt Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/pmc08061360-111-30-35?v=Promega
Average 90 stars, based on 1 article reviews
goscript rt mix oligodt kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
revertra ace qpcr rt master mix  (Toyobo)
99
Toyobo revertra ace qpcr rt master mix
The CSP26G model was applicable for predicting the response to cisplatin in external samples. (A) Schematic representative of A549CR cell establishment and photo images of parental A549 and established A549CR cells are shown. (B) The viabilities of A549 and A549CR cells at 72 h after cisplatin treatment were compared by the MTT assay. Scale bars: 100 μm. Mean ± SD. Significance levels denoted * p < 0.05, ** p < 0.01, and *** p < 0.001. (C) RNA‐seq (resistant/sensitive in the training data for CSP26G) and <t>RT‐qPCR</t> (A549CR/A549) showed positive correlation. The x‐ and y‐axes were shown in log 2 scale, with r denoting the Pearson correlation coefficient and its associated p ‐value. RT‐qPCR data were normalized to GAPDH before fold change calculation. (D) Survival analysis was performed using the Kaplan–Meier method on NSCLC patients with pathological stage II and IIIA ( N = 407) from TCGA, based on CSP26G output results. The solid green and solid orange lines are the survival curves for the sensitive and resistant groups, respectively. The light green and orange shading on the plot represents the 95% CI for each group. Censored patients are shown as markers on the curve. Statistical analysis was conducted using the log‐rank test. (E) ROC curves at 2, 4, 6, and 8 years of treatment in TCGA data were used to estimate predictive accuracies of CSP26G. (F) Forest plot of multivariate Cox proportional hazards regression for overall survival. Hazard ratios and 95% CI are shown for CSP26G prediction score, age, TNM classifications (T, primary tumor and local invasion; N, regional lymph node involvement; M, distant metastasis). Due to the single level of the M stage, its hazard ratio, 95% CI and p ‐value could not be calculated.
Revertra Ace Qpcr Rt Master Mix, supplied by Toyobo, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/pmc12631745-66-17-26?v=Toyobo
Average 99 stars, based on 1 article reviews
revertra ace qpcr rt master mix - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
primescript™ rt reagent kit  (Beijing CWBio)
90
Beijing CWBio primescript™ rt reagent kit
The CSP26G model was applicable for predicting the response to cisplatin in external samples. (A) Schematic representative of A549CR cell establishment and photo images of parental A549 and established A549CR cells are shown. (B) The viabilities of A549 and A549CR cells at 72 h after cisplatin treatment were compared by the MTT assay. Scale bars: 100 μm. Mean ± SD. Significance levels denoted * p < 0.05, ** p < 0.01, and *** p < 0.001. (C) RNA‐seq (resistant/sensitive in the training data for CSP26G) and <t>RT‐qPCR</t> (A549CR/A549) showed positive correlation. The x‐ and y‐axes were shown in log 2 scale, with r denoting the Pearson correlation coefficient and its associated p ‐value. RT‐qPCR data were normalized to GAPDH before fold change calculation. (D) Survival analysis was performed using the Kaplan–Meier method on NSCLC patients with pathological stage II and IIIA ( N = 407) from TCGA, based on CSP26G output results. The solid green and solid orange lines are the survival curves for the sensitive and resistant groups, respectively. The light green and orange shading on the plot represents the 95% CI for each group. Censored patients are shown as markers on the curve. Statistical analysis was conducted using the log‐rank test. (E) ROC curves at 2, 4, 6, and 8 years of treatment in TCGA data were used to estimate predictive accuracies of CSP26G. (F) Forest plot of multivariate Cox proportional hazards regression for overall survival. Hazard ratios and 95% CI are shown for CSP26G prediction score, age, TNM classifications (T, primary tumor and local invasion; N, regional lymph node involvement; M, distant metastasis). Due to the single level of the M stage, its hazard ratio, 95% CI and p ‐value could not be calculated.
Primescript™ Rt Reagent Kit, supplied by Beijing CWBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/pm34737155-58-40-44?v=Beijing+CWBio
Average 90 stars, based on 1 article reviews
primescript™ rt reagent kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
primescript rt master mix  (Beijing CWBio)
90
Beijing CWBio primescript rt master mix
The CSP26G model was applicable for predicting the response to cisplatin in external samples. (A) Schematic representative of A549CR cell establishment and photo images of parental A549 and established A549CR cells are shown. (B) The viabilities of A549 and A549CR cells at 72 h after cisplatin treatment were compared by the MTT assay. Scale bars: 100 μm. Mean ± SD. Significance levels denoted * p < 0.05, ** p < 0.01, and *** p < 0.001. (C) RNA‐seq (resistant/sensitive in the training data for CSP26G) and <t>RT‐qPCR</t> (A549CR/A549) showed positive correlation. The x‐ and y‐axes were shown in log 2 scale, with r denoting the Pearson correlation coefficient and its associated p ‐value. RT‐qPCR data were normalized to GAPDH before fold change calculation. (D) Survival analysis was performed using the Kaplan–Meier method on NSCLC patients with pathological stage II and IIIA ( N = 407) from TCGA, based on CSP26G output results. The solid green and solid orange lines are the survival curves for the sensitive and resistant groups, respectively. The light green and orange shading on the plot represents the 95% CI for each group. Censored patients are shown as markers on the curve. Statistical analysis was conducted using the log‐rank test. (E) ROC curves at 2, 4, 6, and 8 years of treatment in TCGA data were used to estimate predictive accuracies of CSP26G. (F) Forest plot of multivariate Cox proportional hazards regression for overall survival. Hazard ratios and 95% CI are shown for CSP26G prediction score, age, TNM classifications (T, primary tumor and local invasion; N, regional lymph node involvement; M, distant metastasis). Due to the single level of the M stage, its hazard ratio, 95% CI and p ‐value could not be calculated.
Primescript Rt Master Mix, supplied by Beijing CWBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/pm38697105-305-25-17?v=Beijing+CWBio
Average 90 stars, based on 1 article reviews
primescript rt master mix - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
primescript rt reagent kit  (Becton Dickinson)
90
Becton Dickinson primescript rt reagent kit
The CSP26G model was applicable for predicting the response to cisplatin in external samples. (A) Schematic representative of A549CR cell establishment and photo images of parental A549 and established A549CR cells are shown. (B) The viabilities of A549 and A549CR cells at 72 h after cisplatin treatment were compared by the MTT assay. Scale bars: 100 μm. Mean ± SD. Significance levels denoted * p < 0.05, ** p < 0.01, and *** p < 0.001. (C) RNA‐seq (resistant/sensitive in the training data for CSP26G) and <t>RT‐qPCR</t> (A549CR/A549) showed positive correlation. The x‐ and y‐axes were shown in log 2 scale, with r denoting the Pearson correlation coefficient and its associated p ‐value. RT‐qPCR data were normalized to GAPDH before fold change calculation. (D) Survival analysis was performed using the Kaplan–Meier method on NSCLC patients with pathological stage II and IIIA ( N = 407) from TCGA, based on CSP26G output results. The solid green and solid orange lines are the survival curves for the sensitive and resistant groups, respectively. The light green and orange shading on the plot represents the 95% CI for each group. Censored patients are shown as markers on the curve. Statistical analysis was conducted using the log‐rank test. (E) ROC curves at 2, 4, 6, and 8 years of treatment in TCGA data were used to estimate predictive accuracies of CSP26G. (F) Forest plot of multivariate Cox proportional hazards regression for overall survival. Hazard ratios and 95% CI are shown for CSP26G prediction score, age, TNM classifications (T, primary tumor and local invasion; N, regional lymph node involvement; M, distant metastasis). Due to the single level of the M stage, its hazard ratio, 95% CI and p ‐value could not be calculated.
Primescript Rt Reagent Kit, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/10__3727_slash_096504016x14685034103310-59-7-11?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
primescript rt reagent kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
gdna remover kit  (Toyobo)
99
Toyobo gdna remover kit
The CSP26G model was applicable for predicting the response to cisplatin in external samples. (A) Schematic representative of A549CR cell establishment and photo images of parental A549 and established A549CR cells are shown. (B) The viabilities of A549 and A549CR cells at 72 h after cisplatin treatment were compared by the MTT assay. Scale bars: 100 μm. Mean ± SD. Significance levels denoted * p < 0.05, ** p < 0.01, and *** p < 0.001. (C) RNA‐seq (resistant/sensitive in the training data for CSP26G) and <t>RT‐qPCR</t> (A549CR/A549) showed positive correlation. The x‐ and y‐axes were shown in log 2 scale, with r denoting the Pearson correlation coefficient and its associated p ‐value. RT‐qPCR data were normalized to GAPDH before fold change calculation. (D) Survival analysis was performed using the Kaplan–Meier method on NSCLC patients with pathological stage II and IIIA ( N = 407) from TCGA, based on CSP26G output results. The solid green and solid orange lines are the survival curves for the sensitive and resistant groups, respectively. The light green and orange shading on the plot represents the 95% CI for each group. Censored patients are shown as markers on the curve. Statistical analysis was conducted using the log‐rank test. (E) ROC curves at 2, 4, 6, and 8 years of treatment in TCGA data were used to estimate predictive accuracies of CSP26G. (F) Forest plot of multivariate Cox proportional hazards regression for overall survival. Hazard ratios and 95% CI are shown for CSP26G prediction score, age, TNM classifications (T, primary tumor and local invasion; N, regional lymph node involvement; M, distant metastasis). Due to the single level of the M stage, its hazard ratio, 95% CI and p ‐value could not be calculated.
Gdna Remover Kit, supplied by Toyobo, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/pm33579303-306-7-15?v=Toyobo
Average 99 stars, based on 1 article reviews
gdna remover kit - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
primescript rt reagent kit a230-10  (GenStar Biosolutions)
90
GenStar Biosolutions primescript rt reagent kit a230-10
The CSP26G model was applicable for predicting the response to cisplatin in external samples. (A) Schematic representative of A549CR cell establishment and photo images of parental A549 and established A549CR cells are shown. (B) The viabilities of A549 and A549CR cells at 72 h after cisplatin treatment were compared by the MTT assay. Scale bars: 100 μm. Mean ± SD. Significance levels denoted * p < 0.05, ** p < 0.01, and *** p < 0.001. (C) RNA‐seq (resistant/sensitive in the training data for CSP26G) and <t>RT‐qPCR</t> (A549CR/A549) showed positive correlation. The x‐ and y‐axes were shown in log 2 scale, with r denoting the Pearson correlation coefficient and its associated p ‐value. RT‐qPCR data were normalized to GAPDH before fold change calculation. (D) Survival analysis was performed using the Kaplan–Meier method on NSCLC patients with pathological stage II and IIIA ( N = 407) from TCGA, based on CSP26G output results. The solid green and solid orange lines are the survival curves for the sensitive and resistant groups, respectively. The light green and orange shading on the plot represents the 95% CI for each group. Censored patients are shown as markers on the curve. Statistical analysis was conducted using the log‐rank test. (E) ROC curves at 2, 4, 6, and 8 years of treatment in TCGA data were used to estimate predictive accuracies of CSP26G. (F) Forest plot of multivariate Cox proportional hazards regression for overall survival. Hazard ratios and 95% CI are shown for CSP26G prediction score, age, TNM classifications (T, primary tumor and local invasion; N, regional lymph node involvement; M, distant metastasis). Due to the single level of the M stage, its hazard ratio, 95% CI and p ‐value could not be calculated.
Primescript Rt Reagent Kit A230 10, supplied by GenStar Biosolutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/10__1155_slash_jfbc_slash_5515410-65-9-14?v=GenStar+Biosolutions
Average 90 stars, based on 1 article reviews
primescript rt reagent kit a230-10 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hm200 gibson assembly kit neb  (New England Biolabs)
99
New England Biolabs hm200 gibson assembly kit neb
The CSP26G model was applicable for predicting the response to cisplatin in external samples. (A) Schematic representative of A549CR cell establishment and photo images of parental A549 and established A549CR cells are shown. (B) The viabilities of A549 and A549CR cells at 72 h after cisplatin treatment were compared by the MTT assay. Scale bars: 100 μm. Mean ± SD. Significance levels denoted * p < 0.05, ** p < 0.01, and *** p < 0.001. (C) RNA‐seq (resistant/sensitive in the training data for CSP26G) and <t>RT‐qPCR</t> (A549CR/A549) showed positive correlation. The x‐ and y‐axes were shown in log 2 scale, with r denoting the Pearson correlation coefficient and its associated p ‐value. RT‐qPCR data were normalized to GAPDH before fold change calculation. (D) Survival analysis was performed using the Kaplan–Meier method on NSCLC patients with pathological stage II and IIIA ( N = 407) from TCGA, based on CSP26G output results. The solid green and solid orange lines are the survival curves for the sensitive and resistant groups, respectively. The light green and orange shading on the plot represents the 95% CI for each group. Censored patients are shown as markers on the curve. Statistical analysis was conducted using the log‐rank test. (E) ROC curves at 2, 4, 6, and 8 years of treatment in TCGA data were used to estimate predictive accuracies of CSP26G. (F) Forest plot of multivariate Cox proportional hazards regression for overall survival. Hazard ratios and 95% CI are shown for CSP26G prediction score, age, TNM classifications (T, primary tumor and local invasion; N, regional lymph node involvement; M, distant metastasis). Due to the single level of the M stage, its hazard ratio, 95% CI and p ‐value could not be calculated.
Hm200 Gibson Assembly Kit Neb, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primescript+rt+master+mix+reverse+transcription+kit/pm41689803-270-187-191?v=New+England+Biolabs
Average 99 stars, based on 1 article reviews
hm200 gibson assembly kit neb - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


The CSP26G model was applicable for predicting the response to cisplatin in external samples. (A) Schematic representative of A549CR cell establishment and photo images of parental A549 and established A549CR cells are shown. (B) The viabilities of A549 and A549CR cells at 72 h after cisplatin treatment were compared by the MTT assay. Scale bars: 100 μm. Mean ± SD. Significance levels denoted * p < 0.05, ** p < 0.01, and *** p < 0.001. (C) RNA‐seq (resistant/sensitive in the training data for CSP26G) and RT‐qPCR (A549CR/A549) showed positive correlation. The x‐ and y‐axes were shown in log 2 scale, with r denoting the Pearson correlation coefficient and its associated p ‐value. RT‐qPCR data were normalized to GAPDH before fold change calculation. (D) Survival analysis was performed using the Kaplan–Meier method on NSCLC patients with pathological stage II and IIIA ( N = 407) from TCGA, based on CSP26G output results. The solid green and solid orange lines are the survival curves for the sensitive and resistant groups, respectively. The light green and orange shading on the plot represents the 95% CI for each group. Censored patients are shown as markers on the curve. Statistical analysis was conducted using the log‐rank test. (E) ROC curves at 2, 4, 6, and 8 years of treatment in TCGA data were used to estimate predictive accuracies of CSP26G. (F) Forest plot of multivariate Cox proportional hazards regression for overall survival. Hazard ratios and 95% CI are shown for CSP26G prediction score, age, TNM classifications (T, primary tumor and local invasion; N, regional lymph node involvement; M, distant metastasis). Due to the single level of the M stage, its hazard ratio, 95% CI and p ‐value could not be calculated.

Journal: Cancer Medicine

Article Title: Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity

doi: 10.1002/cam4.71373

Figure Lengend Snippet: The CSP26G model was applicable for predicting the response to cisplatin in external samples. (A) Schematic representative of A549CR cell establishment and photo images of parental A549 and established A549CR cells are shown. (B) The viabilities of A549 and A549CR cells at 72 h after cisplatin treatment were compared by the MTT assay. Scale bars: 100 μm. Mean ± SD. Significance levels denoted * p < 0.05, ** p < 0.01, and *** p < 0.001. (C) RNA‐seq (resistant/sensitive in the training data for CSP26G) and RT‐qPCR (A549CR/A549) showed positive correlation. The x‐ and y‐axes were shown in log 2 scale, with r denoting the Pearson correlation coefficient and its associated p ‐value. RT‐qPCR data were normalized to GAPDH before fold change calculation. (D) Survival analysis was performed using the Kaplan–Meier method on NSCLC patients with pathological stage II and IIIA ( N = 407) from TCGA, based on CSP26G output results. The solid green and solid orange lines are the survival curves for the sensitive and resistant groups, respectively. The light green and orange shading on the plot represents the 95% CI for each group. Censored patients are shown as markers on the curve. Statistical analysis was conducted using the log‐rank test. (E) ROC curves at 2, 4, 6, and 8 years of treatment in TCGA data were used to estimate predictive accuracies of CSP26G. (F) Forest plot of multivariate Cox proportional hazards regression for overall survival. Hazard ratios and 95% CI are shown for CSP26G prediction score, age, TNM classifications (T, primary tumor and local invasion; N, regional lymph node involvement; M, distant metastasis). Due to the single level of the M stage, its hazard ratio, 95% CI and p ‐value could not be calculated.

Article Snippet: Total RNA was extracted using the RNeasy mini kit (Qiagen, Hilden, Germany). cDNA was prepared using the ReverTra Ace qPCR RT Master Mix with gDNA Remover (Toyobo, Osaka, Japan).

Techniques: MTT Assay, RNA Sequencing, Quantitative RT-PCR